Abstract
Purpose
Surgical management of bisphosphonate-related osteonecrosis of the jaws (BRONJ) has been performed in an attempt to increase healing rates of the affected cases. This literature review aimed to identify clinical studies of surgical management of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in order to assess their surgical treatment modalities, outcome and the follow-up.
Methods
A search in the PubMed (Medline) database using specific terms and/or phrases as “bisphosphonate-related osteonecrosis” or “jaw osteonecrosis”, and “surgical treatment” or “surgical management” was conducted in order to identify clinical trials and cases of surgical treatment of BRONJ. The review search covered the time period from 2004 to 2014. All studies identified in the search were selected according to the inclusion criteria. Relevant information was recorded according to the following items: author, year, number of patients, BRONJ clinical stage, surgical treatment modality, clinical success, and follow-up.
Results
The initial database search yielded 345 titles. After filtering, 67 abstracts were selected culminating in 67 full text articles. A variety of surgical approach was found in this review: debridement, sequestrectomy bone resection, and bone reconstruction. Adjunctive therapies included hyperbaric oxygen, laser therapy, growth factors, and ozone.
Conclusion
Although there are many indexed studies about BRONJ, well-documented reports concerning surgical therapeutically techniques are scarce, resulting from a lack of well-established protocols. Considerable differences were found regarding sample size, surgical treatment modalities and outcomes. Clinical studies with larger number of patients and longer follow-up are required to provide best information for each surgical treatment modality and its outcomes.
Similar content being viewed by others
References
Russell RG (2011) Bisphosphonates: the first 40 years. Bone 49(1):2–19
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) American association of oral and maxillofacial surgeons. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72(10):1938–1956
Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83(9):1032–1045
Dominguez LJ, Di Bella G, Belvedere M, Barbagallo M (2011) Physiology of the aging bone and mechanisms of action of bisphosphonates. Biogerontology 12(5):397–08
Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA et al (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209–257
Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369
Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433
Ruggiero SL (2011) Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci 1218:38–46
Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis: an American academy of oral medicine position paper. J Am Dent Assoc 136(12):1658–1668
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaw—2009 update. Aust Endod J 35(3):119–130
Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65(3):415–423
Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67(5 Suppl):61–70
Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63(11):1567–1575
Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41(3):318–320
Bagán J, Blade J, Cozar JM, Constela M, García Sanz R, Gómez Veiga F et al (2007) Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Med Oral Patol Oral Cir Bucal 12, E336
Weitzman R, Sauter N, Eriksen EF, Tarassoff PG, Lacerna LV, Dias R et al (2007) Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients—May 2006. Crit Rev Oncol Hematol 62(2):148–152
Cheng A, Mavrokokki A, Carter G, Stein B, Fazzalari NL, Wilson DF et al (2005) The dental implications of bisphosphonates and bone disease. Aust Dent J 50(4 Suppl 2):S4–S13
Lam DK, Sándor GK, Holmes HI, Evans AW, Clokie CM (2007) A review of bisphosphonate-associated osteonecrosis of the jaws and its management. J Can Dent Assoc 73(5):417–422
Curi MM, Cossolin GS, Koga DH, Araújo SR, Feher O, dos Santos MO, Zardetto C (2007) Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases. J Oral Maxillofac Surg 65(2):349–355
Carter GD, Goss NA (2003) Bisphosphonates and avascular necrosis of the jaws. Aust Dent J 48(4):268
Migliorati CA (2003) Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21(22):4253–4254
Pogrel MA (2004) Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 62(3):391–392
Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115–1117
Ruggiero SJ, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527–534
Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J et al (2011) Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. J Oral Maxillofac Surg 69(1):84–91
Badros A, Terpos E, Katodritou E, Goloubeva O, Kastritis E, Verrou E et al (2008) Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol 26(36):5904–5909
Montebugnoli L, Felicetti L, Gissi DB, Pizzigallo A, Pelliccioni GA, Marchetti C (2007) Bisphosphonate associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(4):473–477
Filleul O, Crompot E, Saussez S (2010) Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 136(8):1117–1124
O’Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D et al (2009) Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg 67(7):1363–1372
Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M et al (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23(6):826–836
Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E (2009) Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 20(2):331–336
Williamson RA (2010) Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 39(3):251–255
Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67(5 Suppl):85–95
Wutz A, Biederman E, Wanschitz F, Seemann R, Klug C, Baumann A et al (2008) Treatment results of bisphosphonate-related osteonecrosis of the jaws. Head Neck 30(9):1224–1230
Markose G, Mackensie FR, Currie WJ, Hislop WS (2009) Bisphosphonate osteonecrosis: a protocol for surgical management. Br J Oral Maxillofac Surg 47(4):294–297
Stanton DC, Balasanian E (2009) Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. J Oral Maxillofac Surg 67(5):943–950
Wilde F, Heufelder M, Winter K, Hendricks J, Frerich B, Schramm A, Hemprich A (2011) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111(2):153–163
McLeod NM, Patel V, Kusanale A, Rogers SN, Brennan PA (2011) Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw. Br J Oral Maxillofac Surg 49(5):335–342
Franco S, Miccoli S, Limongelli L, Tempesta A, Favia G, Maiorano E, Favia G (2014) New dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari. Int J Dent 2014:935657
Spinelli G, Torresetti M, Lazzeri D, Zhang YX, Arcuri F, Agostini T, Grassetti L (2014) Microsurgical reconstruction after bisphosphonate-related osteonecrosis of the jaw: our experience with fibula free flap. J Craniofac Surg 25(3):788–792
Lee LW, Hsiao SH, Chen LK (2014) Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws. J Formos Med Assoc 113(3):166–172
Rupel K, Ottaviani G, Gobbo M, Contardo L, Tirelli G, Vescovi P, Di Lenarda R, Biasotto M (2014) A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol 50(11):1049–1057
Longo F, Guida A, Aversa C, Pavone E, Di Costanzo G, Ramaglia L, Ionna F (2014) Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent 2014:298945
Zavalishina L, Karra N, Zaid WS, El-Hakim M (2014) Quality of life assessment in patients after mandibular resection and free fibula flap reconstruction. J Oral Maxillofac Surg 72(8):1616–1626
Vescovi P, Merigo E, Meleti M, Manfredi M, Fornaini C, Nammour S, Mergoni G, Sarraj A, Bagan JV (2014) Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw. Int J Dent 2014:107690
Carlson ER (2014) Management of antiresorptive osteonecrosis of the jaws with primary surgical resection. J Oral Maxillofac Surg 72(4):655–657
Sadiq Z, Sammut S, Lopes V (2014) Non-complex reconstructive techniques in the management of BRONJ: a case series of patient-related outcomes. Oral Maxillofac Surg 18(2):223–227
Soydan SS, Uckan S (2014) Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report. J Oral Maxillofac Surg 72(2):322–326
Stockmann P, Burger M, von Wilmowsky C, Ebker T, Lutz R, Bauersachs A, Nkenke E, Neukam FW, Wehrhan F (2014) The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw—results of a clinical case series with an average follow-up of 20 months. Clin Oral Investig 18(4):1299–1304
Nomura T, Shibahara T, Uchiyama T, Yamamoto N, Shibui T, Yakushiji T, Watanabe A, Muramatsu K, Ogane S, Murayama M, Sekine R, Nakata E, Fujimoto Y (2013) Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic. Bull Tokyo Dent Coll 54(2):117–125
Holzinger D, Seemann R, Klug C, Ewers R, Millesi G, Baumann A, Wutzl A (2013) Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs). Oral Oncol 49(1):66–70
Hanasono MM, Militsakh ON, Richmon JD, Rosenthal EL, Wax MK (2013) Mandibulectomy and free flap reconstruction for bisphosphonate-related osteonecrosis of the jaws. JAMA Otolaryngol Head Neck Surg 139(11):1135–1142
Janovska Z, Mottl R, Slezak R (2015) Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 159(2):313–317
Blus C, Szmukler-Moncler S, Giannelli G, Denotti G, Orrù G (2013) Use of ultrasonic bone surgery (piezosurgery) to surgically treat bisphosphonate-related osteonecrosis of the jaws (BRONJ). a case series report with at least 1 year of follow-up. Open Dent J 7:94–101
Beninati F, Pruneti R, Ficarra G (2013) Bisphosphonate-related osteonecrosis of the jaws (Bronj). Med Oral Patol Oral Cir Bucal 18(5):e752–e758
Freiberger JJ, Padilla-Burgos R, McGraw T, Suliman HB, Kraft KH, Stolp BW, Moon RE, Piantadosi CA (2012) What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. J Oral Maxillofac Surg 70(7):1573–1583
Graziani F, Vescovi P, Campisi G, Favia G, Gabriele M, Gaeta GM, Gennai S, Goia F, Miccoli M, Peluso F, Scoletta M, Solazzo L, Colella G (2012) Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases. J Oral Maxillofac Surg 70(11):2501–2507
Vescovi P, Manfredi M, Merigo E, Guidotti R, Meleti M, Pedrazzi G, Fornaini C, Bonanini M, Ferri T, Nammour S (2012) Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up. Photomed Laser Surg 30(1):5–13
Vescovi P, Merigo E, Meleti M, Manfredi M, Guidotti R, Nammour S (2012) Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med 41(3):214–221
Ferlito S, Puzzo S, Palermo F, Verzì P (2012) Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases. Br J Oral Maxillofac Surg 50(5):425–429
Andriani A, Petrucci MT, Caravita T, Montanaro M, Villivà N, Levi A, Siniscalchi A, Bongarzoni V, Pisani F, De Muro M, Coppetelli U, Avvisati G, Zullo A, Agrillo A, Gaglioti D (2012) Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom’s macroglobulinemia: a retrospective multicentric study. Blood Cancer J 2(3), e62
Jabbour Z, El-Hakim M, Mesbah-Ardakani P, Henderson JE, Albuquerque R Jr (2012) The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series. Int J Oral Maxillofac Surg 41(11):1404–1409
Anitua E, Begoña L, Orive G (2013) Treatment of hemimandibular paresthesia in a patient with bisphosphonate-related osteonecrosis of the jaw (BRONJ) by combining surgical resection and PRGF-Endoret. Br J Oral Maxillofac Surg 51(8):e272–e274
Hewson I, Syme D, Bruscino-Raiola F (2012) Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw. Aust Dent J 57(2):227–230
Cicciù M, Herford AS, Juodžbalys G, Stoffella E (2012) Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw. J Craniofac Surg 23(3):784–788
Mozzati M, Gallesio G, Arata V, Pol R, Scoletta M (2012) Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol 48(5):469–474
Gallego L, Junquera L, Pelaz A, Hernando J, Megías J (2012) The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla. Med Oral Patol Oral Cir Bucal 17(2):e236–e241
Voss PJ, Joshi Oshero J, Kovalova-Müller A, Veigel Merino EA, Sauerbier S, Al-Jamali J, Lemound J, Metzger MC, Schmelzeisen R (2012) Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients. J Craniomaxillofac Surg 40(8):719–725
Schubert M, Klatte I, Linek W, Müller B, Döring K, Eckelt U, Hemprich A, Berger U, Hendricks J (2012) The saxon bisphosphonate register - therapy and prevention of bisphosphonate-related osteonecrosis of the jaws. Oral Oncol 48(4):349–354
Martins MA, Martins MD, Lascala CA, Curi MM, Migliorati CA, Tenis CA, Marques MM (2012) Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study. Oral Oncol 48(1):79–84
Lemound J, Eckardt A, Kokemüller H, von See C, Voss PJ, Tavassol F, Rücker M, Rana M, Gellrich NC (2012) Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap. Clin Oral Investig 16(4):1143–1152
de Souza Faloni AP, Queiroz TP, Comelli Lia RC, Cerri PS, Margonar R, Rastelli AN, Marcantonio E (2011) Accurate approach in the treatment of oral bisphosphonate-related jaw osteonecrosis. J Craniofac Surg 22(6):2185–2190
Curi MM, Cossolin GS, Koga DH, Zardetto C, Christianini S, Feher O, Cardoso CL, dos Santos MO (2011) Bisphosphonate-related osteonecrosis of the jaws—an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J Oral Maxillofac Surg 69(9):2465–2472
Lee CY, Pien FD, Suzuki JB (2011) Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws. Implant Dent 20(5):331–336
Cella L, Oppici A, Arbasi M, Moretto M, Piepoli M, Vallisa D, Zangrandi A, Di Nunzio C, Cavanna L (2011) Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw. Head Face Med 7:16
Atalay B, Yalcin S, Emes Y, Aktas I, Aybar B, Issever H, Mandel NM, Cetin O, Oncu B (2011) Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci 26(6):815–823
Wilde F, Hendricks J, Riese C, Pausch NC, Schramm A, Heufelder M (2011) Bone regeneration without bone grafting after resection of a segment of the mandible to treat bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 69(10):2657–2662
Eckardt AM, Lemound J, Lindhorst D, Rana M, Gellrich NC (2011) Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem. Anticancer Res 31(6):2313–2318
Bedogni A, Saia G, Bettini G, Tronchet A, Totola A, Bedogni G, Ferronato G, Nocini PF, Blandamura S (2011) Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis. Oral Oncol 47(5):420–424
Hoefert S, Eufinger H (2011) Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 69(2):362–380
Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P (2011) Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis. Int J Oral Maxillofac Surg 40(3):277–284
Mücke T, Koschinski J, Deppe H, Wagenpfeil S, Pautke C, Mitchell DA, Wolff KD, Hölzle F (2011) Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res Clin Oncol 137(5):907–913
Scoletta M, Arduino PG, Dalmasso P, Broccoletti R, Mozzati M (2010) Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(1):46–53
Rugani P, Acham S, Truschnegg A, Obermayer-Pietsch B, Jakse N (2010) Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(6):e1–e6
Sacco R, Sacco G, Acocella A, Sale S, Sacco N, Baldoni E (2011) A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis. J Appl Oral Sci 19(4):293–300
Wutzl A, Pohl S, Sulzbacher I, Seemann R, Lauer G, Ewers R, Drach J, Klug C (2012) Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws. Head Neck 34(2):194–200
Stockmann P, Vairaktaris E, Wehrhan F, Seiss M, Schwarz S, Spriewald B, Neukam FW, Nkenke E (2010) Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Support Care Cancer 18(4):449–460
Chiu CT, Chiang WF, Chuang CY, Chang SW (2010) Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw—a serial case analysis. J Oral Maxillofac Surg 68(5):1055–1063
Favia G, Pilolli GP, Maiorano E (2009) Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients. J Rheumatol 36(12):2780–2787
Junquera L, Gallego L, Cuesta P, Pelaz A, de Vicente JC (2009) Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases. Am J Otolaryngol 30(6):390–395
Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, Hughes PJ, Michalowicz BS, Leach JW, Swenson KK, Swift JQ, Adkinson C, Basi DL (2009) Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg 67(9):1904–1913
Cetiner S, Sucak GT, Kahraman SA, Aki SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R (2009) Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab 27(4):435–443
Alons K, Kuijpers SC, de Jong E, van Merkesteyn JP (2009) Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107(2):e1–e7
Saussez S, Javadian R, Hupin C, Magremanne M, Chantrain G, Loeb I, Decaestecker C (2009) Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series. Laryngoscope 119(2):323–329
Engroff SL, Coletti D (2008) Bisphosphonate related osteonecrosis of the palate: report of a case managed with free tissue transfer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105(5):580–582
Aarabi S, Draper L, Grayson B, Gurtner GC (2008) Bisphosphonate-associated osteonecrosis of the jaw: successful treatment at 2-year follow-up. Plast Reconstr Surg 122(2):57e–59e
Adornato MC, Morcos I, Rozanski J (2007) The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 138(7):971–977
Diego R, D’Orto O, Pagani D, Agazzi A, Marzano U, Derada Troletti G, Fontanella W, Pignataro L (2007) Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(3):e1–e5
Borgioli A, Duvina M, Brancato L, Viviani C, Brandi ML, Tonelli P (2007) Bisphosphonate-related osteonecrosis of the jaw: the Florence experience. Clin Cases Miner Bone Metab 4(1):48–52
Lee CY, David T, Nishime M (2007) Use of platelet-rich plasma in the management of oral bisphosphonate-associated osteonecrosis of the jaw: a report of 2 cases. J Oral Implantol 33(6):371–382
Bagán J, Blade J, Cozar JM et al (2007) Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Med Oral Patol Oral Cir Bucal 12(4):E336–E340
Hansen T, Kunkel M, Weber A et al (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates—Histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35(3):155–160
Seth R, Futran ND, Alam DS et al (2010) Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonate-related osteonecrosis of the jaws. Laryngoscope 120(11):2165–2171
Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH (1998) Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin Orthop Relat Res. (355 Suppl):S314-35
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR (1998) Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85(6):638–646
Dugrillon A, Eichler H, Kern S, Klüter H (2002) Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 31(6):615–619
Oyama T, Nishimoto S, Tsugawa T, Shimizu F (2004) Efficacy of platelet-rich plasma in alveolar bone grafting. J Oral Maxillofac Surg 62(5):555–558
Schilephake H (2002) Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31(5):469–484
Bhanot S, Alex JC (2002) Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 18(1):27–33
Schmitz JP, Hollinger JO (2001) The biology of platelet-rich plasma. J Oral Maxillofac Surg 59(9):1119–1121
Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62(4):489–496
Freymiller EG, Aghaloo TL (2004) Platelet-rich plasma: ready or not? J Oral Maxillofac Surg 62(4):484–488
Freymiller EG (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62:1046
Man D, Plosker H, Winland-Brown JE (2001) The use of autólogos platelet-rich plasma (plasma gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 107(1):229–237
Thorn JJ, Sorensen H, Weis-Fogh U, Andersen M (2004) Autologous fibrin glue with growth factors in reconstructive maxillofacial surgery. Int J Oral Maxillofac Surg 33(1):95–100
Arora NS, Ramanayake T, Ren YF, Romanos GE (2009) Platelet-rich plasma: a literature review. Implant Dent 18(4):303–310
Lopez-Vidriero E, Goulding KA, Simon DA, Sanchez M, Johnson DH (2010) The use of plateletrich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy 26(2):269–278
Plachokova AS, Nikolidakis D, Mulder J, Jansen JA, Creugers NH (2008) Effect of plateletrich plasma on bone regeneration in dentistry: a systematic review. Clin Oral Implants Res 19(6):539–545
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Financial source
São Paulo Research Foundation (FAPESP – 2014/10693-6).
Rights and permissions
About this article
Cite this article
Silva, L.F., Curra, C., Munerato, M.S. et al. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review. Oral Maxillofac Surg 20, 9–17 (2016). https://doi.org/10.1007/s10006-015-0538-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-015-0538-x